// App-Quantinova.ai

1142 : The Transfer Of Dabigatran and Rivaroxaban Across a Dually Perfused Isolated Human Placental Cotyledon Implications For Therapy In Pregnancy

Researchers

Presenter

  • Priya Bapat

Principal Investigators

  • Reuven Kedar

  • Nir Melamed

  • Jeremy Matlow

  • Angelika Lubetsky

  • Katarina Aleksa

  • Howard Berger

  • Gideon Koren

Medical Centers

  • Physiology & Pharmacology, University of Western Ontario, London, ON, Canada

  • Department of Clinical Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada

  • Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children Toronto ON, Toronto, ON, Canada

  • Department of Obstetrics & Gynecology, St. Michae-s Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Congestive heart failure

  • Venous thrombosis

  • Arrhythmia

  • Spontaneous abortion

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

  • Evithrom

  • Xarelto

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved